Eucrates Biomedical Acquisition Corp.’s $100 Million Initial Public Offering

Proskauer represented Eucrates Biomedical Acquisition Corp. in the transaction. Eucrates Biomedical Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of effecting…